Novartis AG
Novartis Energy Data Preview
In 2023, Novartis disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Novartis also reported how it meets its energy needs through a mix of purchased and self-generated energy, offering insight into its sourcing strategy and level of energy independence.
Additionally, Novartis also disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
However, Novartis did not provide a breakdown of its energy sources or generation technologies, limiting visibility into its energy mix and the role of renewables versus fossil fuels.
| Metric (GJ) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Renewable Energy Consumed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected energy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Novartis's Energy Renewability
In 2023, Novartis consumed a total of 6.2 million Gigajoules of energy across its operations. Of this total, 45.16% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 54.84% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.
Novartis's Energy Renewability Rate
How much of Novartis's energy consumed is renewable?
In 2023, Novartis consumed a total of 6.2 million Gigajoules of energy, of which 45.16% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.
This moderate level of renewable energy adoption indicates that Novartis is transitioning toward cleaner energy sources, though a significant share of its energy mix still relies on non-renewable inputs.
Insights into Novartis's Energy Inflows & Self-Sufficiency
In 2023, Novartis reported total energy inflows of 2.8 million Gigajoules, which corresponds to the company's full energy needs, including energy consumed, redistributed, sold, or stored. This energy inflow was composed of 2.7 million Gigajoules purchased from external suppliers and 100,000 Gigajoules generated through internal production. This corresponds to a production share of 3.57%, reflecting a 357.14% percentage point increase from the previous year (2022) and a 97.4% percentage point decrease since 2021.
Although Novartis's production share has remained fairly stable over the long term, the increase in the most recent year could signal early momentum toward greater self-reliance. This shift may reflect trial initiatives, newly installed capacity, or short-term operational adjustments.
Novartis's Energy Purchased vs Produced Over Time
- Total Energy Produced
- Total Energy Purchased